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Significant Role for p16INK4a in p53-Independent
Telomere-Directed Senescence
stress from in vitro culturing, making it difficult, if not
impossible, to specifically address the contribution of
p16INK4a to telomere-directed senescence. Here, we
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tional stresses by inducing immediate telomere dys-
function through inhibition of the telomere binding pro-
tein TRF2. When TRF2 is dislodged from telomeres withSummary
a dominant negative allele (TRF2BM), a fraction of chro-
mosome ends lose their protection (reviewed in [20]).Telomere attrition in primary human fibroblasts in-
duces replicative senescence accompanied by activa- The consequences of TRF2 inhibition include degrada-
tion of the telomeric 3 G-overhang by ERCC1/XPF, fu-tion of the p53 and p16INK4a/RB tumor suppressor path-
ways. Although the contribution of p53 and its target, sion of chromosome ends by DNA ligase IV, activation of
ATM, and recruitment of DNA damage response factorsp21, to telomere-driven senescence have been well
established, the role of p16INK4a is controversial. At- such as 53BP1 and the Mre11 complex to telomeres
[21–25]. Loss of the telomeric overhang and associationtempts to dissect the significance of p16INK4a in re-
sponse to telomere shortening have been hampered of DNA damage response factors with telomeres have
also been observed in fibroblasts that have been pas-by the concomitant induction of p16INK4a by cell culture
conditions. To circumvent this problem, we studied saged into senescence [25, 26].
Fibroblasts respond to this TRF2BM-induced telo-the role of p16INK4a in the cellular response to acute
telomere damage induced by a dominant negative al- mere dysfunction by entering a growth arrest that is
indistinguishable from replicative senescence and is ac-lele of TRF2, TRF2BM. This approach avoids the con-
founding aspects of culture stress because parallel companied by the activation of p53, induction of p21,
upregulation of p16INK4a, and hypophosphorylation of RBcultures with and without telomere damage can be
compared. Telomere damagegeneratedwith TRF2BM [27]. Inhibition of p53 with HPV16E6 or a dominant nega-
tive p53 allele (p53175H), or inactivation of RB by HPV16E7resulted in induction of p16INK4a in the majority of cells
as detected by immunohistochemistry. Inhibition of reduces, but does not fully abrogate, this cell cycle ar-
rest [27]. Abrogation of the arrest requires the simultane-p16INK4a with shRNA or overexpression of BMI1 had a
significant effect on the telomere damage response ous inactivation of both p53 and RB by SV40LT or
HPV16E6 and E7 together, suggesting a redundant rolein p53-deficient cells. While p53 deficiency alone only
partially abrogated the telomere damage-induced cell for the p53 and RB pathways in the induction of telo-
mere-directed senescence [27]. These studies showedcycle arrest, combined inhibition of p16INK4a and p53
led to nearly complete bypass of telomere-directed that the RB pathway can mediate telomere-directed cell
cycle arrest in a p53-independent manner, but the spe-senescence. We conclude that p16INK4a contributes to
the p53-independent response to telomere damage. cific contribution of p16 to this pathway was not ad-
dressed.
In order to determine the contribution of p16INK4a toResults and Discussion
telomere-directed senescence, we used RNAi in combi-
nationwith TRF2 inhibition in primary human fibroblasts.The involvement of p16INK4a in telomere-directed senes-
cence has been contentious [1–10]. Telomere attrition Prior to induction of telomere damage with TRF2BM,
we introduced p16INK4a shRNA (either one of two differentin primary cells induces p16INK4a [11–13], and stabilization
of telomeres by telomerase abolishes p16INK4a accumula- target sequences) and/or p53-repressing reagents ac-
cording to the schematic shown in Figure 1A. Cells weretion [14]. This suggests that p16INK4a is upregulated in
response to dysfunctional telomeres and could contrib- kept under selective pressure during the course of the
analysis to prevent loss of TRF2BM expression. Immu-ute to telomere-directed senescence. However, p16INK4a
nofluorescence (IF) detection of TRF2 indicated that allalso responds to numerous telomere-independent
cells retained high levels of TRF2BM over the entirestress signals, including constitutive oncogenic signal-
2-week time course of the analysis (Figure 1C and dataing, DNA damage, and suboptimal in vitro tissue culture
not shown). Inhibition of p16INK4a with shRNA stronglyconditions [4, 15–19]. Previous studies that have ad-
decreased the expression level of p16INK4a and abolisheddressed the role of p16INK4a in telomere-directed senes-
its induction after telomere damage (Figure 1B). Simi-cence typically relied on prolonged in vitro passaging
larly, repression of p53 with a dominant negative alleleof cells until they senesce with shortened telomeres.
(p53175H) or shRNA resulted in diminished p53 activity asHowever, by that time cells have not only sustained
detected by impaired induction of p21. The induction oftelomere damage but have also endured extensive
p16INK4a by telomere damage did not require p53.
We reasoned that if p16INK4a is induced by telomere
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chemistry (IHC) under conditions where virtually all cells
in the culture express the dominant negative allele of
TRF2 (Figure 1C). As expected, p16INK4a was detectable
at variable levels in control cells reflecting theoccasional
induction of p16INK4a by culture conditions. The p16INK4a
staining intensity was dramatically increased in cultures
expressing TRF2BM, and this response was seen in
nearly every cell. Together with the immunoblotting
data, this finding showed that this induction of p16INK4a
is a specific response to telomere damage and not the
consequence of culture stress.
We next determined the contribution of p16INK4a to the
execution of a cell cycle arrest after telomere damage.
The normal response to telomere damage is an arrest
in G1, which can be monitored by diminished incorpora-
tion of BrdU and by lack of cell proliferation [27]. In
cells with severely impaired G1/S checkpoints, BrdU
incorporation is not diminished after telomere damage.
However, such cells still have a growth defect, presum-
ably due to the extensive genome instability resulting
from telomere fusions and the concomitant problems in
mitosis. As expected from previous studies, inhibition
of p53 function with a dominant negative allele (p53175H)
or shRNA partially rescued the proliferation block of
cells expressing TRF2BM (Figures 2A, 2G, and 2H). In
addition, p53 inhibition had a strong effect on the rate
of BrdU incorporation of cells with telomere damage
(Figures 2C, 2E, and 2F). By comparison, the effect of
shRNA-mediated p16INK4a inhibition on the proliferation
of TRF2BM-infected cells was not statistically signifi-
cant (Figure 2). The importance of p53 in mediating the
proliferation block after telomere damagewas also obvi-
ous from TRF2BM expression in human fibroblasts that
have a homozygous intragenic deletion in the p16INK4a
gene [28]. These cells, while lackingp16INK4a function, still
displayed a severe proliferation defect and diminished
BrdU incorporation after introduction of TRF2BM (Fig-
ure 2D and data not shown). Thus, p16INK4a deficiency
alone does not allow a strong by-pass of the telomere Figure 1. Induction of p16INK4a upon TRF2BM-Mediated Telomere
damage-induced arrest. Dysfunction
Although p53 deficiency had an obvious impact on (A) Experimental set-up: IMR90 primary human fibroblasts were se-
the TRF2BM-induced proliferation block, the effect was quentially transduced with 1) pBabeNeo-P53175H, pRetroSuper-
always partial, evenwhenp53was inhibitedwith shRNA. p53sh, or appropriate empty vector control, 2) pRetroSuper-p16sh,
MSCVU6-p16sh, pBabePuro-BMI1, or corresponding vector con-Because this result suggested the presence of a p53-
trol, 3) pBabePuro-TRF2BM, pWZLHygro-TRF2BM, or correspond-independent response to telomere damage, we exam-
ing vector control. The data shown in Figure 2 was obtained withined the role of p16INK4a in this setting. By determining
pRetroSuper-p16sh.MSCVU6-p16shgave similar results. After each
the rate of BrdU incorporation in TRF2BM cultures rela- round of infection, cells were first passaged in medium containing
tive to the appropriate vector control cultures, we cor- neomycin, hygromycin, or puromycin for 7, 4–5, or 3 days, respec-
rected for the effects of p16INK4a and p53 inhibition on tively, before continuing with the next round of infection. After the
final infection with TRF2BM, cells were kept in selective mediumentry into S phase in the absence of TRF2BM. This
during the analysis to prevent loss of the TRF2BM retrovirus.approach removes possible effects of culture stress and
(B) Expression of TRF2BM, p53175H, p21, and p16INK4a proteins inallows specific evaluation of the role of p16INK4a in the
IMR90 cells infected with combinations of empty vector, p16sh-
telomere dysfunction-induced G1/S arrest. The cor- (pRetroSuper), p53175H-, and TRF2BM-encoding retroviruses. Ly-
rected data showed that whereas inhibition of p53 af- sates were prepared on day 17 and equal amounts of protein were
forded a partial escape from TRF2BM-induced growth loaded in each lane (immunoblotting for -tubulin serves as loading
control). At the time point analyzed, the previously documentedarrest, inhibition of both p16INK4a and p53 together re-
induction of endogenous p53 by TRF2BM is no longer detectable.sulted in an almost complete restoration of the rate of
(C) Immunohistochemical analysis of p16INK4a and detection ofDNA synthesis (Figures 2E and 2F; p  1.32 109 [n
TRF2BM by immunofluorescence in primary IMR90 fibroblasts in-17] for the relative effect of p16sh in p53175H cells). This
fected with control, p16sh-, or TRF2BM-encoding retroviruses on
indicates that in absence of p53, p16INK4a is an inhibitor day 8.
of entry into S phase after telomere damage.
Immunofluorescence analysis of TRF2 expression
confirmed that the observed rescue in DNA synthesis
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Figure 2. Inhibition of p16INK4a Cooperates
with p53 Inactivation in Abrogating TRF2BM-
Induced Growth Arrest
(A) Inhibition of p53 alone partially alleviates
TRF2BM–induced growth arrest. Growth
curves of IMR90 primary human fibroblasts
infected with pRetroSuper-p53sh and/or
pBabePuro-TRF2BM retroviruses. Standard
deviations were less than 10%.
(B) Inhibition of p16 alone does not signifi-
cantly improve the proliferation of cells with
TRF2BM-induced telomere damage. Growth
curves of IMR90 cells infected with MSCVU6-
p16sh and/or pWZLH-TRF2BM retroviruses.
Standard deviations were less than 10%.
(C) S phase index in TRF2BM-espressing
IMR90 cells shown in (A) and (B) measured
by BrdU incorporation on day 8.
(D) Growth curves of p16INK4a-deficient human
diploid fibroblasts after infection with a
pBabePuro-TRF2BM retrovirus. Standard
deviations were less than 10%
(E) BrdU incorporation rates (on day 8) of
primary IMR90 fibroblasts infected with
pBabe-Neo-p53175H or pBabe-Neo control
and pRetroSuper-p16sh or pRetroSuper con-
trol retroviruses followed by pBabePuro-
TRF2BM or pBabePuro control retroviruses.
(F) Relative BrdU incorporation rates of pri-
mary IMR90 fibroblasts infected with combi-
nations of vector control, p53175H-, and p16sh-
encoding retroviruses. Averages from three
independent experiments using two different
p16sh vectors (pRetroSuper-p16sh and
MSCVU6-p16sh) are shown.
(G) Growth rates of IMR90 cells infected with
pBabeNeo-p53175H or pBabeNeo control and
pRetroSuper-p16sh or pRetroSuper control
followed by pBabePuro-TRF2BM or pBabe-
Puro control retroviruses. Growth rates were
determined by calculating the average in-
crease in population doublings over days
3–11 of selection from five experiments (three
independent infections).
(H)Growth rates of TRF2BM-espressing cells
in G, relative to their respective vector con-
trols.
by combined p53 and p16INK4a inhibition was not due to of IMR90 fibroblasts (Figures 2G–2H).Whereas inhibition
of p53 alone resulted in partial rescue of TRF2BM-an increased outgrowth of cells with diminished
TRF2BM expression (Figure 1C and data not shown). induced growth arrest, a significantly better rescue was
observed in cultures in which both p16INK4a and p53 wereOn the contrary, TRF2BM expression levels appeared
higher in cells with inhibited p53 and p16INK4a expression inactivated (p  1.30x106 [n  5] for the relative effect
of pRetroSuper-p16sh in p53175H cells in Figure 2H; p than in controls, especially at later time points when
controls cells showed decreased TRF2BM expression 0.0196 [n  3] for the relative effect of a second shRNA,
MSCVU6-p16sh in p53175H cells [data not shown]).(data not shown). This suggests a greater tolerance for
telomere damage and thus less selection against Although the rescue of DNA synthesis by combined
inactivation of p16INK4a and p53 was almost completeTRF2BM in cells lacking both p53 and p16INK4a function.
To assess the effect of p16INK4a on the proliferation of (90%; Figure 2F), the cells still showed a somewhat
reduced proliferation rate (70%–80%; Figure 2H). Thisp53 deficient cells with telomere damage, we measured
culture growth rates during the 2 weeks following infec- can be explained by the deleterious effects of telomere
fusions, which include anaphase bridges, chromosometion with the TRF2BM retrovirus. Cultures were not fol-
lowed longer because after 2–3 weeks, cells with low- nondisjunction, translocations, and deletions [22]. So
even though the downstream signaling response to telo-ered levels of TRF2BM begin to appear. TRF2BM
expression resulted in a 60% reduction in proliferation mere dysfunction might be disabled through p53 and
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Table 1. Chromosome End Fusions in IMR90 Cells Expressing TRF2BM
% Metaphases with Number of Fusions
Retroviruses Chromosome Fusions per Metaphase
vector 0 (n  35) 0
TRF2BM 37 (n  27) 0.56
TRF2BM  p16sh 41 (n  22) 0.55
TRF2BM  p53175H 64 (n  22) 1.68
TRF2BM  p16sh  p53175H 53 (n  30) 1.33
TRF2BM  BMI1  p53175H 60 (n 20) 2.0
p16INK4a inactivation, telomere damage still results in le- result further illustrates that in absence of p53, p16INK4a
has an important role in inducing senescence in re-thal genome instability. Indeed, metaphase spreads of
TRF2BM-expressing cells with inhibited p16INK4a and sponse to telomere damage.
As an independent way of inhibiting p16INK4a, we ex-p53 function contained multiple chromosome end fu-
sions (Table 1). This excludes the fact that the observed pressed the Polycomb-group repressor BMI1 alone and
in combination with p53175H in IMR90 fibroblasts andp16/p53-mediated rescue of the growth arrest induced
by TRF2BM is due to improved telomere protection. In investigated the response to TRF2BM. BMI1 represses
the expression of both p16INK4a and the second productfact, the frequency of chromosome fusions in cells with
inhibited p16INK4a and p53 function, as well as in of the INK4a locus p19ARF and has been shown to extend
the replicative lifespan of mouse and human fibroblastsTRF2BM-expressing cells with inactivated p53 only,
was higher than in TRF2BM-expressing cells with nor- [6, 30]. BMI1 prevented the induction of p16INK4a upon
TRF2BM expression, indicating that increased Poly-mal p53 and p16INK4a function. This is consistent with our
observations that these cells have a diminished ability comb-group repression on the INK4a locus is dominant
over the mechanism that drives p16 upregulation uponto arrest in response to TRF2BM-induced telomere dys-
function. telomere dysfunction (Figure 4A).Consistent with our re-
sults from using RNA interference to inhibit p16INK4a,Besides growth arrest and upregulation of cell cycle
inhibitors, other characteristics of senescent cells are BMI1 significantly reduced the proliferation-inhibiting
effect of TRF2BM, especially in combination with p53their flat morphology and staining for senescence-asso-
ciated -galactosidase (SA--galactosidase) [29]. Al- inhibition (Figures 4B–4D).
Telomere-directed senescence is regarded as amajorthough a significant reduction in these parameters was
seen, especially for p53175H cultures, flat and SA- tumor suppressor mechanism by limiting the outgrowth
of potentially tumorigenic cells (reviewed in [31–34]).-galactosidase positive cells were still observed in
p53175H or p16sh IMR90 cultures expressing TRF2BM Telomeres whose functionality has been compromised
as a result of extensive attrition of telomeric DNA or(Figure 3). However, TRF2BM-expressing cultures in
which both p53 andp16INK4a were inhibitedweremorpho- due to reduced function of telomere capping proteins
behave like chromosome internal double-strand breaks,logically indistinguishable from control cultures and
negative for SA--galactosidase activity (Figure 3). This resulting in cell cycle arrest and senescence or apopto-
Figure 3. Inhibition of Both p53 and p16INK4a Abolishes Senescent Morphology and SA--Galactosidase Activity in Primary IMR90 Fibroblasts
with Dysfunctional Telomeres
IMR90primary fibroblasts infectedwith combinations of empty vector control, p53175H-, p16sh- (pRetroSuper), or TRF2BM-encoding retroviruses
and stained for SA--galactosidase activity at day 12.
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Figure 4. The p16INK4a-Repressor BMI1 Atten-
uates the Senescence Response to TRF2BM
(A) p53175H, BMI1, TRF2BM, and p16INK4a pro-
tein levels in IMR90 cells shown in (B)–(D) at
day 12 of selection. Equal amounts of protein
were loaded in each lane.
(B) S phase index of primary IMR90 fibro-
blasts infected with combinations of control,
BMI1-, p53175H-, and TRF2BM-encoding re-
troviruses at day 8 of selection.
(C) Average growth rates of IMR90 fibroblasts
infected with BMI1- and/or p53175H-encoding
retroviruses followed by pWZLH or pWZLH-
TRF2BM. Growth rates were determined
over days 4–12 from three duplicate experi-
ments (two independent infections).
(D) Relative growth rates of IMR90 fibroblasts
in which p16INK4a was repressed by BMI1 and
p53 was inhibited by p53175H expression or
shRNA. Graph represents results from three
independent duplicate experiments.
sis. In cells with impaired DNA damage response check- as a surrogate for telomere shortening. For instance,
our strategy forces us to analyze relatively early timepoints, dysfunctional telomeres can induce genome in-
stability and a complex spectrum of genetic alterations points at which p16INK4a might not yet be at its maximum
due to its slow induction, resulting in the predominancethat promotes tumorigenesis (reviewed in [32, 35]). Re-
cent data provided evidence for loss of telomere func- of the faster p53-dependent response.
A recent study of replicative senescence at the single-tion and the associated genome instability early in hu-
man breast cancer at the transition to ductal carcinoma cell level concluded that p16INK4a is not involved in senes-
cence triggered by telomere shortening [9], a conclusionin situ [36]. These considerations underscore the need
for detailed understanding of the cellular response to that is discordant with the findings reported here. This
conclusion was based on the lack of a correlation be-deprotected telomeres.
Here, we have used TRF2 inhibition as a tool to induce tween the presence of -H2AX foci (an indicator of telo-
mere dysfunction) and upregulation of p16INK4a, whereasimmediate telomere dysfunction in order to specifically
address the contributionof thep53andp16INK4a/RBpath- this correlation did exist for p21. However, the formation
of -H2AX foci and the induction of p16INK4a occur withways to the telomere damage response. We found that
p53 plays a major role but that p16INK4a is also clearly different kinetics. DNA damage foci are formed immedi-
ately (within hours) after telomere deprotection and theyresponsible for a substantial part of telomere-directed
senescence in primary human fibroblasts. Thus, p16INK4a are transient [23, 38]. By contrast, the induction of
p16INK4A after telomere dysfunction appears to be a veryprovides an important additional fail-safe that prevents
unlimited proliferation in the presence of telomere dam- slow process. After retroviral infection of TRF2BM, it
takes one or two weeks before p16INK4a is readily detect-age even when the p53 pathway is disrupted. A similar
observation was made recently in a study on the revers- able, a time point at which the -H2AX foci will have
disappeared. Therefore, it would be expected that cellsibility of human cellular senescence, in which it was
found that p53 inactivation only resulted in the reversal with high levels of p16INK4a are generally devoid of
-H2AX foci and vice versa, explaining the lack of corre-of senescence in cells with low levels of p16INK4a and not
in cells with high levels of p16INK4a [37]. However, in that lation observed. Thus, our finding that p16INK4a is a signifi-
cant mediator of telomere-directed senescence is notstudy, as well as in a different study addressing the
contribution of p16INK4a to senescence by transient trans- necessarily in conflict with the data of Herbig et al. [9].
The signal through which dysfunctional telomeres ac-fection of siRNA [8], cells were extensively passaged
until a senescent state was reached. Therefore, the tivate p53 and RB has not been fully established; how-
ever, the telomere damage response has the hallmarksp16INK4a response probably at least in part reflects a
reaction to accumulated culture stress and does not of a DNA damage response and is transmitted through
the ATM and ATR kinases [23, 25, 39]. The resultingdirectly address the role of p16INK4a in the telomere dam-
age pathway. activation of p53 by phosphorylation leads to increased
expression of p21, which activates RB family proteinsAlthough the effect of p16INK4a inhibition on TRF2BM-
induced growth arrest in p53-deficient cells is very clear, by inhibiting their phosphorylation by cyclin dependent
kinases [40]. Targeted disruption of p21 alone has beenthe effect wasminimal in p53-proficient cells.We cannot
exclude that this is in part related to the use of TRF2BM shown to be sufficient to abolish senescence in human
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quential extension of proliferative lifespan in human fibroblastsfibroblasts [41]. In our study, inactivation of p53, which
induced by over-expression of CDK4 or 6 and loss of p53 func-prevents the p53-mediated increase in p21, only partially
tion. Oncogene 21, 4277–4288.abrogated TRF2BM-induced senescence and full by-
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